Patents Assigned to Serenity Pharmaceuticals LLC
  • Safe desmopressin administration
    Patent number: 11419914
    Abstract: Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: August 23, 2022
    Assignee: Serenity Pharmaceuticals LLC
    Inventor: Seymour Fein
  • Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
    Patent number: 10568927
    Abstract: The invention provides methods and compositions for use of desmopressin in combination with a beta-3-adrenergic receptor agonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: February 25, 2020
    Assignee: Serenity Pharmaceuticals LLC
    Inventors: Seymour H. Fein, Samuel Herschkowitz
  • Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
    Patent number: 10286033
    Abstract: The invention provides methods and compositions for use of desmopressin in combination with an alpha-adrenergic receptor antagonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: May 14, 2019
    Assignee: Serenity Pharmaceuticals, LLC
    Inventors: Seymour H. Fein, Linda Cheng, Maria Cheng, Samuel Herschkowitz
  • Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
    Patent number: 9925232
    Abstract: The invention provides methods and compositions for use of desmopressin in combination with a 5-alpha reductase inhibitor. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: March 27, 2018
    Assignee: Serenity Pharmaceuticals, LLC
    Inventors: Seymour H. Fein, Linda Cheng, Maria Cheng, Samuel Herschkowitz
  • Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
    Patent number: 9814753
    Abstract: The invention provides methods and compositions for use of desmopressin in combination with a beta-3-adrenergic receptor agonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: November 14, 2017
    Assignee: Serenity Pharmaceuticals LLC
    Inventors: Seymour H. Fein, Samuel Herschkowitz